🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Turkey / NCT06568341
Recruiting Observational

Turkish Validity-Reliability of the Outcome Expectations For Yoga Scale

NCT06568341 · tracked via the Priya Life Science Turkey tracker
Sponsor
Hacettepe University
Phase
Observational
Started
2024-09-01
Last updated
2026-02-25

Condition(s) studied

Adults

Investigational drug(s) / intervention(s)

validity and reability study

validity and reability study: Validity and reliability assessment of the Turkish version of the Outcome Expectations For Yoga (OEY) Scale

Study summary

Evaluation of the Turkish validity and reliability of the outcome Expectations for Yoga (OEY) Scale, which was developed to evaluate attitudes and beliefs related to yoga practice

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18 years and older Exclusion Criteria: * Pregnant women * Body Mass Index above 40 * Practiced yoga, Tai Chi, Qi Gong, or a mindfulness-based therapy program 2 times or more in the past month or 10 times in the past year

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hacettepe University Faculty of Physical Therapy and Rehabilitation Ankara Altindag Recruiting
Çankiri Karatekin University Çankırı Turkey (Türkiye) Recruiting

More Hacettepe University trials in Turkey

High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability Levels Recruiting
Animation-Based Education to Reduce Child and Parent Anxiety During Pediatric Stem Cell Transplantation (Cartoon-HSCT) Starting soon
Telerehabilitation vs. Home Exercise in Piriformis Syndrome: A Comparative Study Enrolling by invitation
Effectiveness of Respiratory Muscle Training with a Mobile Application After Lobectomy Starting soon
Resisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises Recruiting

Other trials for the same condition

Turkish Version of Digital Eye Strain Questionnaire (DESQ) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06568341 on ClinicalTrials.gov ↗ ← All trials in Turkey